Valneva Announces the Cancellation of Ordinary Shares Held by the Company following Termination of its Liquidity Agreement

by NASDAQ Market News October 4, 2021

NASDAQ Market News
Click here to email author

SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of Valneva SE (VALN) and Encourages Investors With More Than $50,000 in Losses to Contact the Firm

AB Science receives FDA authorization to start clinical development program of masitinib in mast cell activation syndrome (MCAS)

Ads